Cyclerion Therapeutics (CYCN) Retained Earnings (2019 - 2025)
Cyclerion Therapeutics (CYCN) has 7 years of Retained Earnings data on record, last reported at -$270.2 million in Q3 2025.
- For Q3 2025, Retained Earnings changed N/A year-over-year to -$270.2 million; the TTM value through Sep 2025 reached -$270.2 million, changed N/A, while the annual FY2023 figure was -$264.4 million, 1321985.0% down from the prior year.
- Retained Earnings reached -$270.2 million in Q3 2025 per CYCN's latest filing, roughly flat from -$269.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$16000.0 in Q1 2024 and bottomed at -$270.3 million in Q2 2023.
- Average Retained Earnings over 5 years is -$202.1 million, with a median of -$251.9 million recorded in 2022.
- Peak YoY movement for Retained Earnings: surged 99.99% in 2024, then plummeted 1680656.25% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$23000.0 in 2021, then increased by 13.04% to -$20000.0 in 2022, then crashed by 1321985.0% to -$264.4 million in 2023, then decreased by 1.09% to -$267.3 million in 2024, then dropped by 1.09% to -$270.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Retained Earnings were -$270.2 million in Q3 2025, -$269.2 million in Q2 2025, and -$268.9 million in Q1 2025.